Man Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-25,281
| Closed | -$894K | – | 2374 |
|
|
2026
Q1 | $894K | Buy |
+25,281
| New | +$1.03M | ﹤0.01% | 1875 |
|
|
2025
Q3 | – | Sell |
-4,603
| Closed | -$240K | – | 2254 |
|
|
2025
Q2 | $240K | Buy |
4,603
+780
| +20% | +$42.8K | ﹤0.01% | 2015 |
|
|
2025
Q1 | $231K | Buy |
+3,823
| New | +$246K | ﹤0.01% | 1997 |
|
|
2024
Q3 | – | Sell |
-232,473
| Closed | -$16.1M | – | 2001 |
|
|
2024
Q2 | $16.1M | Buy |
232,473
+97,818
| +73% | +$7.14M | 0.04% | 503 |
|
|
2024
Q1 | $10.8M | Buy |
+134,655
| New | +$12M | 0.03% | 671 |
|
|
2022
Q4 | – | Sell |
-16,862
| Closed | -$1.35M | – | 2026 |
|
|
2022
Q3 | $1.35M | Buy |
+16,862
| New | +$1.59M | 0.01% | 1193 |
|
|
2022
Q2 | – | Sell |
-56,550
| Closed | -$6.79M | – | 873 |
|
|
2022
Q1 | $8.4M | Buy |
56,550
+394
| +0.7% | +$55K | 0.03% | 677 |
|
|
2021
Q4 | $7.96M | Sell |
56,156
-4,179
| -7% | -$592K | 0.03% | 685 |
|
|
2021
Q3 | $7.89M | Buy |
60,335
+1,989
| +3% | +$260K | 0.03% | 661 |
|
|
2021
Q2 | $8.02M | Buy |
58,346
+26,849
| +85% | +$3.68M | 0.03% | 691 |
|
|
2021
Q1 | $4.11M | Sell |
31,497
-6,825
| -18% | -$821K | 0.02% | 789 |
|
|
2020
Q4 | $4.29M | Buy |
38,322
+15,827
| +70% | +$1.5M | 0.02% | 894 |
|
|
2020
Q3 | $1.77M | Buy |
22,495
+15,895
| +241% | +$1.3M | 0.01% | 1228 |
|
|
2020
Q2 | $475K | Sell |
6,600
-15,963
| -71% | -$1.11M | ﹤0.01% | 1461 |
|
|
2020
Q1 | $1.29M | Sell |
22,563
-120,423
| -84% | -$11.1M | 0.01% | 1045 |
|
|
2019
Q4 | $16M | Buy |
142,986
+137,462
| +2,488% | +$14.6M | 0.05% | 445 |
|
|
2019
Q3 | $531K | Sell |
5,524
-22,133
| -80% | -$2.08M | ﹤0.01% | 1563 |
|
|
2019
Q2 | $2.37M | Sell |
27,657
-88,954
| -76% | -$7.31M | 0.01% | 1250 |
|
|
2019
Q1 | $9.7M | Sell |
116,611
-22,684
| -16% | -$1.65M | 0.04% | 578 |
|
|
2018
Q4 | $8.94M | Sell |
139,295
-112,819
| -45% | -$7.72M | 0.04% | 501 |
|
|
2018
Q3 | $20M | Buy |
252,114
+46,483
| +23% | +$3.6M | 0.07% | 325 |
|
|
2018
Q2 | $15.1M | Buy |
205,631
+50,803
| +33% | +$3.45M | 0.06% | 381 |
|
|
2018
Q1 | $9.81M | Buy |
+154,828
| New | +$9.24M | 0.04% | 503 |
|
Other funds holding CNMD
ICM
Man Group's CNMD Position: Q2 2026 in Review
Man Group sold out of CONMED (CNMD) in Q2 2026, closing a stake of 25,281 shares — an estimated $894K sold.
Man Group first reported a position in CNMD in Q1 2018 and held it in 23 quarters. The position peaked at $20M in Q3 2018. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Man Group reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
- Man Group sold 25,281 CONMED shares in Q2 2026, an estimated $894K.
- Man Group first reported a position in CONMED in Q1 2018 and held it in 23 quarters.
- Man Group's CONMED position peaked at $20M in Q3 2018.
- 247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.